Answers are grounded in this paper and cite their sources.
To the Editor: It is considered potentially harmful to administer imipenem–cilastatin to patients with IgE-mediated hypersensitivity to penicillins1 because of a 47.4 percent rate of cross-reactivi...
No takes yet. Share an insight, caveat, or question.
Romano et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: